These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7878985)

  • 1. Cell interactions and cytokines in transplantation immunity.
    Möller E
    Transplant Proc; 1995 Feb; 27(1):24-7. PubMed ID: 7878985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dendritic cells and T cell activation in allograft rejection.
    Roake JA; Austyn JM
    Exp Nephrol; 1993; 1(2):90-101. PubMed ID: 8081962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
    Thorsby E; Pfeffer P; Leivestad T
    Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
    Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.
    Waldman WJ; Knight DA
    Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation and cytokines.
    Bumgardner GL; Orosz CG
    Semin Liver Dis; 1999; 19(2):189-204. PubMed ID: 10422200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK; Koh MB; Lowdell MW
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.